Japanese Government Procurement
National Hospital Organization - Notice of Procurement (Goods & Services)aimovig Subcutaneous Injection Pens and 246 others
This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.
| Publishing date | Aug 09, 2024 |
|---|---|
| Type of notice | Notice of Procurement (Goods & Services) |
| Procurement entity | National Hospital Organization - Tokyo |
| Classification |
0004 Medical & Pharmaceutical Products |
| Summay of notice | ⑴ Official in charge of disbursement of the procuring entity : Hirotoshi Matsui, Director, National Hospital Organization Tokyo National Hospital ⑵ Classification of the products to be procured : 4 ⑶ Nature and quantity of the products to be purchased : aimovig Subcutaneous Injection Pens and 246 others ⑷ Fulfillment period : From October 1, 2024 through September 30, 2025 ⑸ Delivery place : National Hospital Organization Tokyo National Hospital ⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : ① not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ; ② not come under Article 6 of the Regulation concerning Contract for NHO ; ③ have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Kanto-Koshinetsu Re- gion ; ④ Be a person who has license of pharmaceutical sales business based on Pharmaceutical Affairs Law ⑤ Among the items shown in the "Pharmaceuticals Procurement List" issued separately, those who bid on narcotics are those who have a license for narcotics and drug shelf wholesale business based on the provision of Article 3 paragraph 1 of the Act on Control of Psychotropic Drugs about ; ⑥ meet the qualification requirements which the Obligating Officer may specify in accordance with Article 4 of the Regulation ; ⑺ Time-limit for tender : 17 : 00 September 25, 2024 ⑻ Contact point for the notice : Kaoruko Sawada, Accounting Division, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka Kiyose-shi Tokyo 204-8585, Japan. TEL 042-491-2918 ext. 1998 |
